10/31/2025
We had an incredible few days connecting with clinicians, researchers, and partners at 2025.
Thank you to everyone who stopped by our booth — our team was proud to share how StemCyte’s FDA-licensed REGENECYTE™ and GMP-standard cell starting materials are driving innovation in transplant and cell therapy.
Learn more about REGENECYTE™ and download our company profile: https://is.gd/VOGXvt
Cell starting material inquiries: research@stemcyte.com